Advanced Enzyme Technologies has received an approval for making additional investment not exceeding MYR 300,000, in one or more tranches, in shares of Advanced Enzymes (Malaysia), subsidiary (AEM). The board of directors at its meeting held on February 19, 2018 approved the same.
The acquisition of remaining 20% stake i.e. 50,000 equity shares of face value of MYR 1 each will be made from the existing other shareholders of AEM. On completion of the said acquisition, AEM would become wholly owned subsidiary of the company. The balance investment will be by way of subscription, purchase or otherwise of shares of AEM, in one or more tranches.
Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1515.00 |
Dr. Reddys Lab | 6080.25 |
Cipla | 1565.50 |
Zydus Lifesciences | 1110.95 |
Lupin | 1601.00 |
View more.. |